Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrimmune (G17DT) in Advanced Pancreatic Carcinoma
NCT02098291Phase 2Completed
- Sponsor
- Cancer Advances, Inc.
- Start
- Apr 1999
- Primary completion
- Jul 2001
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of G17DT immunogen in pancreatic carcinoma, sponsored by Cancer Advances, Inc.. Started Apr 1999; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
pancreatic carcinoma
Beyond the preview
Go deeper on NCT02098291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098291.